Harald Arnesen Selected Research

Harald Arnesen Research Topics

Disease

53	Myocardial Infarction 04/2022 - 09/2002
35	ST Elevation Myocardial Infarction 04/2022 - 07/2005
27	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 10/2002
24	Atrial Fibrillation 01/2022 - 06/2007
21	Atherosclerosis 01/2022 - 01/2002
20	Thrombosis (Thrombus) 04/2022 - 02/2003
17	Infarction (Infarctions) 04/2022 - 10/2003
16	Coronary Disease (Coronary Heart Disease) 08/2020 - 01/2002
12	Heart Failure 04/2022 - 01/2009
12	Inflammation (Inflammations) 09/2020 - 11/2006
11	Stroke (Strokes) 01/2022 - 09/2002
11	Type 2 Diabetes Mellitus (MODY) 12/2021 - 03/2010
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 03/2009
10	Hemorrhage 01/2022 - 09/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2004
6	Hypertension (High Blood Pressure) 09/2021 - 04/2007
6	Thrombophilia 12/2020 - 08/2012
5	Heart Diseases (Heart Disease) 09/2020 - 04/2012
5	Stable Angina 01/2017 - 11/2009
5	Acute Coronary Syndrome 04/2016 - 01/2010
4	Necrosis 12/2021 - 01/2013
3	Glucose Intolerance 10/2019 - 01/2009
3	Insulin Resistance 01/2019 - 04/2007
3	Hyperlipidemias (Hyperlipidemia) 01/2016 - 03/2005
3	Ischemia 03/2014 - 01/2010
2	Diabetes Mellitus 09/2021 - 12/2012
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2020
2	Albuminuria 01/2019 - 01/2017
2	Vascular Diseases (Vascular Disease) 01/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

15	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 09/2002
12	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2002
11	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2021 - 03/2005
11	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2009
9	Interleukin-18 (Interleukin 18)IBA 01/2019 - 03/2009
8	Troponin T (Troponin T1)IBA 01/2021 - 07/2014
8	Thromboplastin (Tissue Factor)IBA 01/2020 - 01/2003
8	Thrombin FDA Link 10/2018 - 02/2003
7	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2005
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2011
7	fibrin fragment D (D-dimer)IBA 10/2018 - 04/2006
7	AnticoagulantsIBA 04/2016 - 02/2003
7	candesartanIBA 01/2016 - 06/2007
7	Clopidogrel (Plavix)FDA Link 08/2012 - 12/2004
6	pro-brain natriuretic peptide (1-76)IBA 12/2022 - 01/2009
6	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 11/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2008
6	Prothrombin (Factor II)IBA 10/2018 - 01/2010
6	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2012 - 02/2003
6	Warfarin (Coumadin)FDA LinkGeneric 04/2012 - 09/2002
5	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2011
5	Insulin (Novolin)FDA Link 01/2020 - 04/2007
5	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2018 - 01/2010
5	Chemokine CX3CL1IBA 01/2016 - 12/2012
5	Nitric Oxide Synthase (NO Synthase)IBA 02/2011 - 02/2003
4	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2022 - 03/2005
4	Peroxidase (Myeloperoxidase)IBA 01/2020 - 12/2015
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 01/2009
4	Tissue Inhibitor of MetalloproteinasesIBA 01/2018 - 11/2009
4	Trinitrotoluene (TNT)IBA 05/2016 - 01/2014
4	CytokinesIBA 01/2016 - 03/2010
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2012 - 12/2004
4	Arginine (L-Arginine)FDA Link 02/2011 - 02/2003
3	Plasminogen Activator Inhibitor 1IBA 04/2022 - 01/2008
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2017
3	apixabanIBA 01/2022 - 04/2012
3	Eicosapentaenoic AcidIBA 01/2022 - 09/2020
3	Docosahexaenoic AcidsIBA 01/2022 - 01/2016
3	Phospholipids (Phosphatides)FDA LinkGeneric 09/2021 - 01/2004
3	Galectin 3 (LGALS3)IBA 08/2021 - 12/2015
3	AcidsIBA 01/2021 - 06/2008
3	Fatty Acids (Saturated Fatty Acids)IBA 09/2020 - 10/2002
3	Interleukin-8 (Interleukin 8)IBA 01/2020 - 01/2014
3	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2019 - 01/2014
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 10/2010
3	Troponin IIBA 09/2018 - 01/2016
3	Vitamin K FDA Link 04/2016 - 04/2012
3	Cytokine Receptor gp130IBA 01/2016 - 07/2013
3	C-Reactive ProteinIBA 01/2016 - 09/2012
3	Angiotensin II Type 1 Receptor BlockersIBA 01/2016 - 08/2007
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016 - 01/2013
3	MB Form Creatine KinaseIBA 01/2016 - 12/2010
3	CD40 Ligand (CD40L)IBA 12/2015 - 09/2012
3	Tenecteplase FDA Link 08/2014 - 01/2010
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013 - 11/2009
2	Plasminogen Activators (Plasminogen Activator)IBA 04/2022 - 01/2013
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022 - 01/2010
2	AdiponectinIBA 12/2021 - 07/2010
2	Linoleic Acid (Linoleate)IBA 09/2021 - 12/2019
2	Corn Oil (Oil, Corn)IBA 01/2021 - 01/2006
2	InflammasomesIBA 01/2021 - 01/2019
2	Sirtuin 1IBA 08/2020 - 01/2019

Therapy/Procedure

25	Percutaneous Coronary Intervention 01/2017 - 04/2004
14	Therapeutics 01/2017 - 09/2002
9	Stem Cell Transplantation 09/2014 - 07/2005
8	Electric Countershock (Cardioversion) 01/2016 - 06/2007
4	Patient Readmission 10/2018 - 01/2016
4	Secondary Prevention 04/2012 - 09/2002
3	Stents 06/2010 - 11/2009
2	Glycemic Control 01/2020 - 01/2020